(Q60194288)

English

High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis

scientific article published on 28 October 2011

In more languages
default for all languages
No label defined

No description defined

Statements

High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit